Shanghai Runda Med Tech Co
Shanghai Runda Medical Technology Co., Ltd. provides medical laboratory services primarily in China. It also engages in the research and development, manufacturing, sale, and service of in vitro diagnostic products, including reagents and other consumables; medical solutions to help healthcare professionals in the areas of diabetes, POCT, clinical chemistry, and immunoassay; professional technica… Read more
Shanghai Runda Med Tech Co - Asset Resilience Ratio
Shanghai Runda Med Tech Co (603108) has an Asset Resilience Ratio of 0.42% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how Shanghai Runda Med Tech Co's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Runda Med Tech Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥57.80 Million | 0.42% |
| Total Liquid Assets | CN¥57.80 Million | 0.42% |
Asset Resilience Insights
- Limited Liquidity: Shanghai Runda Med Tech Co maintains only 0.42% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Runda Med Tech Co Industry Peers by Asset Resilience Ratio
Compare Shanghai Runda Med Tech Co's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for Shanghai Runda Med Tech Co (2017–2024)
The table below shows the annual Asset Resilience Ratio data for Shanghai Runda Med Tech Co.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.57% | CN¥82.20 Million | CN¥14.31 Billion | +0.17pp |
| 2023-12-31 | 0.41% | CN¥58.00 Million | CN¥14.31 Billion | -0.33pp |
| 2022-12-31 | 0.73% | CN¥106.50 Million | CN¥14.52 Billion | +0.52pp |
| 2021-12-31 | 0.21% | CN¥25.49 Million | CN¥12.02 Billion | -1.45pp |
| 2020-12-31 | 1.67% | CN¥169.60 Million | CN¥10.18 Billion | +0.34pp |
| 2019-12-31 | 1.33% | CN¥120.00 Million | CN¥9.03 Billion | -0.28pp |
| 2017-12-31 | 1.61% | CN¥114.50 Million | CN¥7.13 Billion | -- |